Prostate tumor engines (IMAGE)
Caption
In three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androgen receptor (shown in red) as an engine.
Credit
Courtesy of Joshi Alumkal
Usage Restrictions
None
License
Original content